Reaktogenicitetsprofilen for Fendrix hos raske forsøgspersoner var generelt sammenlignelig med bivirkningsprofilen set hos præ- hæmodialyse - og hæmodialysepatienter.
The reactogenicity profile of Fendrix in healthy subjects was generally comparable to that seen in pre- haemodialysis and haemodialysis patients.